Jeil Pharma Holdings Inc (KRX:002620)

Jeil Pharma Holdings Statistics

Total Valuation

KRX:002620 has a market cap or net worth of KRW 126.19 billion. The enterprise value is 350.64 billion.

Market Cap	126.19B
Enterprise Value	350.64B

Important Dates

The last earnings date was Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

KRX:002620 has 15.35 million shares outstanding. The number of shares has increased by 1.72% in one year.

Current Share Class	15.35M
Shares Outstanding	15.35M
Shares Change (YoY)	+1.72%
Shares Change (QoQ)	-0.24%
Owned by Insiders (%)	76.13%
Owned by Institutions (%)	0.03%
Float	2.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.16
PB Ratio	0.28
P/TBV Ratio	0.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 36.28, with an EV/FCF ratio of -29.86.

EV / Earnings	-7.17
EV / Sales	0.45
EV / EBITDA	36.28
EV / EBIT	n/a
EV / FCF	-29.86

Financial Position

The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.36.

Current Ratio	1.12
Quick Ratio	0.76
Debt / Equity	0.36
Debt / EBITDA	16.64
Debt / FCF	-13.69
Interest Coverage	-0.54

Financial Efficiency

Return on equity (ROE) is -13.99% and return on invested capital (ROIC) is -0.46%.

Return on Equity (ROE)	-13.99%
Return on Assets (ROA)	-0.31%
Return on Invested Capital (ROIC)	-0.46%
Return on Capital Employed (ROCE)	-0.84%
Revenue Per Employee	20.89B
Profits Per Employee	-1.32B
Employee Count	37
Asset Turnover	0.88
Inventory Turnover	4.46

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.19% in the last 52 weeks. The beta is 0.86, so KRX:002620's price volatility has been lower than the market average.

Beta (5Y)	0.86
52-Week Price Change	-19.19%
50-Day Moving Average	7,930.60
200-Day Moving Average	8,152.95
Relative Strength Index (RSI)	58.26
Average Volume (20 Days)	8,204

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:002620 had revenue of KRW 773.03 billion and -48.91 billion in losses. Loss per share was -3,160.21.

Revenue	773.03B
Gross Profit	216.13B
Operating Income	-4.34B
Pretax Income	-55.09B
Net Income	-48.91B
EBITDA	9.67B
EBIT	-4.34B
Loss Per Share	-3,160.21

Balance Sheet

The company has 70.55 billion in cash and 160.80 billion in debt, giving a net cash position of -90.25 billion or -5,878.80 per share.

Cash & Cash Equivalents	70.55B
Total Debt	160.80B
Net Cash	-90.25B
Net Cash Per Share	-5,878.80
Equity (Book Value)	443.62B
Book Value Per Share	20,155.64
Working Capital	42.13B

Cash Flow

In the last 12 months, operating cash flow was -7.80 billion and capital expenditures -3.94 billion, giving a free cash flow of -11.74 billion.

Operating Cash Flow	-7.80B
Capital Expenditures	-3.94B
Free Cash Flow	-11.74B
FCF Per Share	-764.99

Margins

Gross margin is 27.96%, with operating and profit margins of -0.56% and -6.33%.

Gross Margin	27.96%
Operating Margin	-0.56%
Pretax Margin	-7.13%
Profit Margin	-6.33%
EBITDA Margin	1.25%
EBIT Margin	-0.56%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 0.61%.

Dividend Per Share	50.00
Dividend Yield	0.61%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.72%
Shareholder Yield	-1.12%
Earnings Yield	-38.76%
FCF Yield	-9.31%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 17, 2006. It was a forward split with a ratio of 10.

Last Split Date	Apr 17, 2006
Split Type	Forward
Split Ratio	10

Scores

KRX:002620 has an Altman Z-Score of 1.2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.2
Piotroski F-Score	n/a